HLA-B*44 and the Bw4-80T motif are associated with poor outcome of relapse-preventive immunotherapy in acute myeloid leukemia.

Cancer Immunol Immunother · 2023 · PMC10576699 · PMID 37597015

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

The findings regarding B*44 and B-80I versus 80 T remained highly significant (Supplementary Tables 1 and 2).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.